Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 3/20 | 0.41 |
| ▸ | NSD2 | O96028 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MTOR | P42345 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.41 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.41 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.41 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4202380 | 0.90 | CYP19A1 (0.50) | CYP19A1MEN1BLMKMT2ARECQL | |
| Hydrochloric Acid SCHEMBL4197847 | 0.88 | RECQL (0.49) | CYP19A1MEN1BLMKMT2ARECQL | |
| SCHEMBL4885984 | 0.80 | CYP19A1 (0.68) | CYP19A1MEN1BLMKMT2ARECQL | |
| SCHEMBL29350310 | 0.80 | CYP19A1 (0.68) | CYP19A1MEN1BLMKMT2ARECQL | |
| SCHEMBL11517791 | 0.80 | CYP19A1 (0.68) | CYP19A1MEN1BLMKMT2ARECQL | |
| Hydrochloric Acid SCHEMBL7204221 | 0.79 | CYP19A1 (0.66) | CYP19A1MEN1BLMKMT2ARECQL | |
| SCHEMBL29886736 | 0.78 | MEN1 (0.63) | CYP19A1MEN1BLMKMT2ARECQL | |
| SCHEMBL4198607 | 0.78 | MEN1 (0.63) | CYP19A1MEN1BLMKMT2ARECQL | |
| SCHEMBL4200289 | 0.77 | NPSR1 (0.44) | CYP19A1MEN1BLMKMT2ARECQL | |
| SCHEMBL4189278 | 0.77 | NQO1 (0.43) | CYP19A1MEN1BLMKMT2ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156807-A1 | Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone | ISHMAEL D RICHARD | 2009-06-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156807-A1 | Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone | CASP4, CASP8, CASP1 | CYP19A1 2871/4885MEN1 2002/4885BLM 2631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.